Background: Asthma is the most common chronic respiratory disease, affecting 1% to 18% of population worldwide. It characterized by various symptoms, such as wheezing, shortness breath, chest tightness and cough, variable airflow limitation. People with asthma often have periods worsened symptoms airway obstruction called exacerbations, which can be fatal. We would like provide updated clinical...

An Appropriate Use of Accelerated Approval The FDA decision to grant accelerated approval aducanumab for Alzheimer’s disease fits squarely in the pathway, which was created ...